chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Toes and left side had pin prick feeling and itchy; Toes and left side had pin prick feeling and itchy; "sign and symptoms of mini covid-19 experience; Severe itching; Welt and blister; extremely firery red; sensation of pin pricking on the area of injection site; Nose started running; Hot and cold chills; Arm ached; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PARAESTHESIA (sensation of pin pricking on the area of injection site), RHINORRHOEA (Nose started running), PARAESTHESIA (Toes and left side had pin prick feeling and itchy), PRURITUS (Toes and left side had pin prick feeling and itchy) and VACCINATION FAILURE ("sign and symptoms of mini covid-19 experience) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (omentum removed 2021) and Food allergy (sensitivity to chicken and eggs).    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced VACCINATION SITE PAIN (Arm ached). On 24-Apr-2021, the patient experienced VACCINATION SITE PARAESTHESIA (sensation of pin pricking on the area of injection site), RHINORRHOEA (Nose started running), VACCINATION FAILURE ("sign and symptoms of mini covid-19 experience), VACCINATION SITE PRURITUS (Severe itching), VACCINATION SITE URTICARIA (Welt and blister), VACCINATION SITE ERYTHEMA (extremely firery red) and CHILLS (Hot and cold chills). 24-Apr-2021, the patient experienced PRURITUS (Toes and left side had pin prick feeling and itchy). On 25-Apr-2021, the patient experienced PARAESTHESIA (Toes and left side had pin prick feeling and itchy). At the time of the report, VACCINATION SITE PARAESTHESIA (sensation of pin pricking on the area of injection site), RHINORRHOEA (Nose started running), PARAESTHESIA (Toes and left side had pin prick feeling and itchy), PRURITUS (Toes and left side had pin prick feeling and itchy), VACCINATION FAILURE ("sign and symptoms of mini covid-19 experience), VACCINATION SITE PRURITUS (Severe itching), VACCINATION SITE URTICARIA (Welt and blister), VACCINATION SITE ERYTHEMA (extremely firery red) and CHILLS (Hot and cold chills) outcome was unknown and VACCINATION SITE PAIN (Arm ached) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Allergic reaction; Eyes swollen; Rash like hives in neck and face; Rash like hives in neck; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction), EYE SWELLING (Eyes swollen), URTICARIA (Rash like hives in neck and face) and RASH (Rash like hives in neck) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction), EYE SWELLING (Eyes swollen), URTICARIA (Rash like hives in neck and face) and RASH (Rash like hives in neck). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Adverse event, at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Allergic reaction), EYE SWELLING (Eyes swollen), URTICARIA (Rash like hives in neck and face) and RASH (Rash like hives in neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
2days p/recv vax pt devel a pinpoint rash on back & front of trunk,  arms, legs.
Small blisters that resemble chicken pox; This non-serious case was reported by a consumer via call center representative and described the occurrence of blister in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20-MAR-2023, the patient received the 2nd dose of Shingrix (left arm). On 21-MAR-2023, 1 days after receiving Shingrix, the patient experienced blister (Verbatim: Small blisters that resemble chicken pox). The outcome of the blister was unknown.   It was unknown if the reporter considered the blister to be related to Shingrix.     It was unknown if the company considered the blister to be related to Shingrix.   Additional Information: GSK Receipt date: 21-MAR-2023 The consumer was the reporter. The patient had her 2nd Shingrix vaccination administered in her left arm and she has small blisters on her left arm that resemble chicken pox. The patient declined to provide any other information, including consent, MD name and phone number and consumer address.  No further information was known. The reporter did not consent to follow up.
Information has been received from a father referring to his 14 year old son. The patient had no pertinent medical history and no drug reactions/allergies. On 17-APR-2015 the patient was vaccinated with dose 1 of GARDASIL (lot#, route and dose unknown). There was no concomitant medication. On 19-APR-2015 the patient experienced stomach aches, fever, being tired, unspecified aches, and being bed ridden after received GARDASIL. The reporter could not confirm whether the vaccines was GARDASIL or GARDASIL 9. There was no treatment and no lab given to the event. The therapy was reported as continued and patient did not seek medical attention. The outcome of the events was reported as not recovered/not resolved. No PQC involved. Additional information has been requested.
thrombocytopenia - maybe detected by blood test during annual physical  Oct 2021 - PLT 47 (8 months after vaccination). SEP 2019 - PLT 107 (14 months before vaccination)
Patient received her first dose of Moderna COVID-19 vaccine on 4/10/21. Vaccine was administered 0839. In the observation lot, patient complained of tingling sensation in her tongue. This started 10 min after vaccine administration. She was observed for 40 min and the tingling sensation persisted. No dyspnea or hives. No throat swelling. She was assessed by Dr and given diphenhydramine 25 mg po x1. Her tingling sensation improved. She was deemed stable for discharge.
This spontaneous report as received from a pharmacist refers to a 87 years old female patient with no pertinent medical history or drug reactions/allergies. The patient was vaccinated SC with single dose of live ZOSTAVAX (lot # reported as H01049, exp. 05-SEP-2013) into her left arm on 28-DEC-2012. Concomitant therapy including unspecified eye drops. On 30-DEC-2012 the patient experienced redness and soreness at injection site, 3 days after onset of therapy and soreness at injection site. The patient came to pharmacy for medical attention. The patient had self-treated with TYLENOL. The outcome of redness and soreness at injection site was reported as recovering/resolving. Additional information has been requested.
This spontaneous report was received from a medical assistant referring to a 66 year old female patient with drug reaction/allergy to nitrofurantoin (manufacturer unknown) (linked case 1705USA014917). Concomitant therapies included estrogens, conjugated (PREMARIN) and multivitamins (manufacturer unknown). On 19-MAY-2017, the patient was vaccinated with a dose of PNEUMOVAX23 intramuscular in the right deltoid, for prophylaxis, lot # M039060 with expiration date of 22-MAY-2018 (dose and frequency were not reported). It was reported that, on an unknown date in May 2017, the patient developed a rash on her right inner arm above the elbow, but not at the injection site, it was described as red, raised, hot to the touch, and itchy. The patient sought medical attention, however, treatment was not given, no laboratories diagnostics were performed, no intervention to prevent seriousness criteria was performed, no significant disability or incapacity occurred, no life threatening happened and no hospitalization was needed.   At the time of reporting the rash had not grown in size, but also had not improved (not recovered). The causality between rash, rash papular, skin warm, rash pruritic and rash erythematous with PNEUMOVAX23 was not reported. Additional information has been requested.; Sender's Comments: US-009507513-1705USA014917:
Initial misuse report received from a healthcare professional on 15 March 2013. A patient had received a dose of MENACTRA in the past and inadvertently received a second dose of MENACTRA on an unspecified date. No adverse event was reported. List of documents held by sender: none.
Around 930am-received HPV vaccine along with meningitis and whooping cough-it took about 2-3 minutes after the shot was given and we were leaving then my daughter said she was dizzy and couldn't see-when I tried to help her walk towards a chair to sit-she passed out-completely unconscious face was white-when Dr took her blood pressure it was 63/40.
A spontaneous report was received from a Consumer concerning a 85-years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events itch at injection site, red at injection site, hard at injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 30 Jan 2021, the patient experienced the events itch at injection site, red at injection site, hard at injection site.  She did put cortisone cream on it and took a Benadryl. It is better now.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events itch at injection site, red at injection site, hard at injection site was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Body aches, chills, extreme fatigue, fever of 101.0, chest pressure and sore throat. Treatment include Tylenol with no improvement.
Patient has had prolonged and abnormal menstrual cycle with bleeding for 3 months since receiving the first dose of the Pfizer vaccine, she also complains of increased emotional response, pain in her left ovary, and extreme fatigue
Asthma like. Rattle in breath and unproductive cough.  Zyrtec controlled the symptoms.
Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.; Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.) and DEVICE CONNECTION ISSUE (Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.) and DEVICE CONNECTION ISSUE (Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.). At the time of the report, UNDERDOSE (Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.) and DEVICE CONNECTION ISSUE (Vaccine came out of a joint between the needle and syringe  and he  must have missed the portion of  the dose.) had resolved.            No concomitant medications were reported.  No treatment information was provided.
Severe night sweats, every night since first injection up until now. In beginning, enough sweat to wring out of an undershirt. Aching in previous areas affected by gout--wrist and foot.
Ringing in my ears at bedtime. No pain or clogged ears. Also, when quiet and focused can hear it then as well, brain fog, off balance at morning. No treatment after over the phone consultation.
VISION FADING; RINGING IN EARS; FEELING OF LACK OF BLOOD (CIRCULATION CUT OFF) IN LEFT SIDE OF BODY INCLUDING LEFT LEGS AND LEFT ARM; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-DEC-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-DEC-2021, the patient experienced feeling of lack of blood (circulation cut off) in left side of body including left legs and left arm. On 09-DEC-2021, the patient experienced vision fading. On 09-DEC-2021, the patient experienced ringing in ears. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from vision fading, and ringing in ears, and had not recovered from feeling of lack of blood (circulation cut off) in left side of body including left legs and left arm. This report was non-serious.
Swelling in arm and hot to touch, patient also reported chest pain and heaviness in her chest. She called the pharmacy on 9-8-18 and after describing her symptoms I recommended she call her doctor. She then was instructed to go to ER. She was dehydrated and was diagnosed with cellulitis. She was given cephalexin and doxycycline. Her daughter picked up the prescriptions on 9-9-18 and stated she was doing much better.
Narrative:  12/21/22 - Pt sent to ED from community residential care facility for hypotension, generalized body weakness (GBW), body aches x 1 day. Pt reported chills and muscle pain. In ED, Pt tested COVID +. Pt given 1L NS IVF considering tachycardia / likely dehydration, rectal Tylenol, cefepime IV. Pt will be admitted to hospital 12/21 d/t COVID-19, GBW, body aches and abnormal chest x-ray (possible pneumonia). Pt admitted 12/21/22 through 1/20/23. PRINCIPAL DIAGNOSIS (Reason for admission after study): Acute hypoxic respiratory failure secondary to COVID and possibly aspiration pneumonia. ADDITIONAL DIAGNOSES: Acute on chronic dysphagia due to cervical osteophyte complex COVID viral pneumonia Schizoaffective disorder Syncope Hypothyroidism Hospital Course: 1. Acute COVID 19 infection/pneumonia - clinically resolved. Completed course of remdesivir and decadron. 2. Acute hypoxic respiratory failure due to COVID 19 and possible bacterial pneumonia - resolved. No evidence of PE on Chest CTA. S/P cefepime x 7 days 3. Dysphagia - Failed MBSS badly, per both SLP and radiologist there is little change of recovery short of potential surgery. Osteophyte complex. Community provider has accepted for transfer, but no beds right now. Pt will be transferred to facility for evaluation of osteophytes once bed is available. 4. Hypothyroidism - TSH high nl range cont levoxyl repeat TSH in 4- 6 weeks 5. Syncope, resolved - likely related to hypotension. No further evaluation. 6. Schizoaffective ds, PTSD - Stable, at baseline. Cont Haldol 150mg q4weeks (last dose 12/8/22) Given mentation/sensorium concerns and low plts MH recommended to d/c Valproate (mood instability hx). Can be reconsidered in future as an outpatient, with close monitoring of labs 7. DVT ppx- hep sc
First dose: flu-like symptoms; temperature was 102-103 degrees, His temperature would probably lower to 100 degrees at times and then go back; he received the first dose of the COVID vaccine on 25Mar2021, and confirms starting on 04Apr2021 he started to feel bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 25Mar2021 (Lot number: EP6955) at the age of 33 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 04Apr2021, outcome "recovered" (07Apr2021), described as "First dose: flu-like symptoms"; PYREXIA (non-serious) with onset 04Apr2021, outcome "recovered" (07Apr2021), described as "temperature was 102-103 degrees, His temperature would probably lower to 100 degrees at times and then go back"; FEELING ABNORMAL (non-serious) with onset 04Apr2021, outcome "recovered" (07Apr2021), described as "he received the first dose of the COVID vaccine on 25Mar2021, and confirms starting on 04Apr2021 he started to feel bad".  Additional information: After the 1st shot, the patient experienced a 3-day adverse reaction that started about 10 days after the first vaccine. No additional vaccine was administered on same date of the Pfizer suspect. The events did not result in emergency room or physician office. The Patient believes he was running a consistent temperature of around 102-103 degrees.   No follow-up attempts are possible. No further information is expected.
she mentioned that while getting the other two vaccines, they kind of pinch your skin and this one here, she just put it straight through.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 06Mar2021 (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "very bad back" (unspecified if ongoing), notes: the joint pain cause we have a third back. The patient's concomitant medications were not reported. The following information was reported: SKIN DISCOMFORT (non-serious), outcome "unknown", described as "she mentioned that while getting the other two vaccines, they kind of pinch your skin and this one here, she just put it straight through.".  Additional information: While reporting for her husband, she mentioned that while getting the other two vaccines,  they kind of pinch your skin and this one here, she just put it straight through. This report completed for her injection going straight through. Caller reported, "we have that anyway, the joint pain cause we have a third back, or very bad back, and we've had them before, the day we got shot, he got back pain and pain shooting on his legs after we got them"  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Within a few minutes my ears began to ring and within 30 minutes my sight got blurry and light flashes seemed to appear, then about an hour to hour and a half I broke out in a itchy bright red rash. I went to the ER and they gave me Prednisone through an IV and Benadryl through an IV and also a bag of fluids through an IV. I was released from the ER around 6:30 to 7:00 pm and had to pick up a prescription for Prednisone 20 mg x3 for 5 days.
Case number PHEH2014US024369, is an initial spontaneous report received from a nurse on 02 DEC 2014, with a follow up received from nurse on 21 JAN 2015. This report refers to a 79 years old male patient. His medical history was not reported. Concomitant medications were none. The patient had tolerated the vaccines well in the past. He was vaccinated with FLUVIRIN 2014/2015 (batch number: 14511P, expiry date: MAR 2015) intramuscularly at a dose of 0.5 ml into the right deltoid on 06 NOV 2014. Nurse reported that PFS of FLUVIRIN was stored at 49 degrees for 1 hour and 15 minutes. The patient did not experience any adverse reaction due to the maladministration (incorrect storage of drug). Follow up received from nurse on 21-JAN 2015: updated site of vaccination and reporter comment.
I started to feel unwell on Thursday June 9th, 2022 with a runny nose, sore throat and cough. By Saturday I felt bad enough to take the home COVID19 test that came back positive immediately. I went to urgent care I let them know that I had tested positive for COVID 19 they asked me some questions and prescribed my PAXLOVID. Had I not had a positive COVID 19 test I would have thought this was a regular Spring or Summer cold.
Patient woke up every hour that night irritable. He complained of abdominal pain, loss of appetite, and diarrhea. Patient favored the leg where the shot was administered, complained of pain, was limping, and crying for 2-3 days are the shot. There was no redness or swelling at the injection site according to the patient's dad. Also, patient started to have stuttering that lasted for 1 week after receiving the vaccine. The stuttering has since completely resolved.
2/24/2021 admitted to hospital with hypoxia, lethargy, rash, altered mental status with HA. Altered mental status with HA, could be due to metabolic encephalopathy and reaction to COVID-19 vaccine.  Will check ABG, CT head. Hold gabapentin. Check depakote level.   Rash, likely due to allergic reaction to COVID-19 vaccine, hx of reaction to first COVID-19 vaccine with fever needing hospitalization. Start patient on Solu-Medrol and Pepcid.  Benadryl p.r.n.   Suspected right lower extremity cellulitis, start patient on Ancef.  Check MRSA, will rule out right DVT   Abn CXR, Bilateral LE edema, CXR seems stable to me, clinically no pneumonia. He does not have "hypoxia" when I was in room, however assisted living reporte  2/24/2021 admitted to hospital with hypoxia, lethargy, rash, altered mental status with HA. Altered mental status with HA, could be due to metabolic encephalopathy and reaction to COVID-19 vaccine.  Will check ABG, CT head. Hold gabapentin. Check depakote level.    Rash, likely due to allergic reaction to COVID-19 vaccine, hx of reaction to first COVID-19 vaccine with fever needing hospitalization. Start patient on Solu-Medrol and Pepcid.  Benadryl p.r.n.   Suspected right lower extremity cellulitis, start patient on Ancef.  Check MRSA, will rule out right DVT   Abn CXR, Bilateral LE edema, CXR seems stable to me, clinically no pneumonia. He does not have "hypoxia" when I was in room, however assisted living reported he was hypoxic this AM, wife said he was wheezy on Sunday could be due to acute on chronic diastolic congestive heart failure, IV Lasix x1. reeval in AM.  Echo TTE is pending   Abdominal pain and distension, CT abdomen without contrast to rule out other etiology that can cause altered mental status   Hx of COVID-19 pneumonia, history of CVA with dense right hemiplegia and expressive aphasia, chronic atrial fibrillation, depression, Will reorder home meds after pharmacist reconciles medication list   Generalized weakness, PT/OT   DVT prophylaxis warfarin and SCD